Koyfin Home > Directory > Health Care > Amicus Therapeutics

Amicus Therapeutics Price Chart FOLD

Historical daily share price chart and data for Amicus Therapeutics since 2007 adjusted for splits and dividends. The latest closing price for Amicus Therapeutics as of October 17, 2019 is $8.18.
  • In 2019 the stock opened at $9.43 and closed at $8.18 for a loss of -15% YTD.
  • In 2018 the stock opened at $14.53 and closed at $9.58 for a loss of -52%.
  • In 2017 the stock opened at $5.08 and closed at $14.39 for a gain of 65%.
  • In 2016 the stock opened at $9.40 and closed at $4.97 for a loss of -89%.
View Chart On Koyfin

Amicus Therapeutics Summary

Stock Symbol: FOLD

Amicus Therapeutics Company Info

Amicus Therapeutics, Inc., a biotechnology company, engages in the discovery, development, and commercialization of medicines for various rare and orphan diseases. The company offers Galafold, an orally administered small molecule pharmacological chaperone for the treatment of Fabry disease. It is also conducting a Phase 1/2 clinical study of ATB200-02 for indications, including pompe disease. The company has a strategic alliance with GlaxoSmithKline plc to develop and commercialize Galafold as a monotherapy and in combination with ERT for Fabry disease, as well as a research and development collaboration with the University of Pennsylvania to develop AAV gene therapies; and a strategic manufacturing agreement with Catalent Biologics. The company has a strategic manufacturing collaboration with Thermo Fisher Scientific for conducting preclinical and clinical-stage gene therapy programs for CLN6, CLN3, and other Batten disease programs. Amicus Therapeutics, Inc. was founded in 2002 and is headquartered in Cranbury, New Jersey.
Market Cap
Dividend Yield
0 %
Beta vs SPX
Short Interest
3136.55 %
30D Volatility
Hedge Fund Held
21.17 %

Last 10 Days of FOLD Prices